Nosocomiale Infecties in België, deel II: Impact op Mortaliteit ... - KCE
Nosocomiale Infecties in België, deel II: Impact op Mortaliteit ... - KCE
Nosocomiale Infecties in België, deel II: Impact op Mortaliteit ... - KCE
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
86 Nosocomial Infections – Mortality and Costs <strong>KCE</strong> reports 102<br />
22. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource<br />
use associated with catheter-related bloodstream <strong>in</strong>fection <strong>in</strong> the surgical <strong>in</strong>tensive care unit.<br />
Arch Surg. 2001;136(2):229-34.<br />
23. Johnson DW, MacG<strong>in</strong>ley R, Kay TD, Hawley CM, Campbell SB, Isbel NM, et al. A randomized<br />
controlled trial of t<strong>op</strong>ical exit site mupiroc<strong>in</strong> application <strong>in</strong> patients with tunnelled, cuffed<br />
haemodialysis catheters. Nephrol Dial Transplant. 2002;17(10):1802-7.<br />
24. Liu JW, Su YK, Liu CF, Chen JB. Nosocomial blood-stream <strong>in</strong>fection <strong>in</strong> patients with end-stage<br />
renal disease: excess length of hospital stay, extra cost and attributable mortality. J Hosp Infect.<br />
2002;50(3):224-7.<br />
25. Orsi GB, Di Stefano L, Noah N. Hospital-acquired, laboratory-confirmed bloodstream<br />
<strong>in</strong>fection: <strong>in</strong>creased hospital stay and direct costs. Infect Control Hosp Epidemiol.<br />
2002;23(4):190-7.<br />
26. Rosenthal VD, Guzman S, Migone O, Crnich CJ. The attributable cost, length of hospital stay,<br />
and mortality of central l<strong>in</strong>e-associated bloodstream <strong>in</strong>fection <strong>in</strong> <strong>in</strong>tensive care departments <strong>in</strong><br />
Argent<strong>in</strong>a: A prospective, matched analysis. Am J Infect Control. 2003;31(8):475-80.<br />
27. Song X, Sr<strong>in</strong>ivasan A, Plaut D, Perl TM. Effect of nosocomial vancomyc<strong>in</strong>-resistant enterococcal<br />
bacteremia on mortality, length of stay, and costs. Infect Control Hosp Epidemiol.<br />
2003;24(4):251-6.<br />
28. Wispl<strong>in</strong>ghoff H, Cornely OA, Moser S, Bethe U, Stutzer H, Salzberger B, et al. Outcomes of<br />
nosocomial bloodstream <strong>in</strong>fections <strong>in</strong> adult neutr<strong>op</strong>enic patients: a prospective cohort and<br />
matched case-control study. Infect Control Hosp Epidemiol. 2003;24(12):905-11.<br />
29. Dietrich ES, Demmler M, Schulgen G, Fekec K, Mast O, Pelz K, et al. Nosocomial pneumonia: a<br />
cost-of-illness analysis. Infection. 2002;30(2):61-7.<br />
30. Warren DK, Shukla SJ, Olsen MA, Kollef MH, Hollenbeak CS, Cox MJ, et al. Outcome and<br />
attributable cost of ventilator-associated pneumonia among <strong>in</strong>tensive care unit patients <strong>in</strong> a<br />
suburban medical center. Crit Care Med. 2003;31(5):1312-7.<br />
31. Lai KK, Fontecchio SA. Use of silver-hydrogel ur<strong>in</strong>ary catheters on the <strong>in</strong>cidence of catheterassociated<br />
ur<strong>in</strong>ary tract <strong>in</strong>fections <strong>in</strong> hospitalized patients. Am J Infect Control. 2002;30(4):221-<br />
5.<br />
32. Tambyah PA, Knas<strong>in</strong>ski V, Maki DG. The direct costs of nosocomial catheter-associated<br />
ur<strong>in</strong>ary tract <strong>in</strong>fection <strong>in</strong> the era of managed care. Infect Control Hosp Epidemiol.<br />
2002;23(1):27-31.<br />
33. Plowman R, Graves N, Griff<strong>in</strong> MA, Roberts JA, Swan AV, Cookson B, et al. The rate and cost<br />
of hospital-acquired <strong>in</strong>fections occurr<strong>in</strong>g <strong>in</strong> patients admitted to selected specialties of a district<br />
general hospital <strong>in</strong> England and the national burden imposed. J Hosp Infect. 2001;47(3):198-209.<br />
34. Blot SI, Depuydt P, Annemans L, Benoit D, Hoste E, De Waele JJ, et al. Cl<strong>in</strong>ical and economic<br />
outcomes <strong>in</strong> critically ill patients with nosocomial catheter-related bloodstream <strong>in</strong>fections. Cl<strong>in</strong><br />
Infect Dis. 2005;41(11):1591-8.<br />
35. Pirson M, Dramaix M, Struelens M, Riley TV, Leclercq P. Costs associated with hospitalacquired<br />
bacteraemia <strong>in</strong> a Belgian hospital. J Hosp Infect. 2005;59(1):33-40.<br />
36. Pirson M, Leclercq P, Jackson T, Leclercq M, Garr<strong>in</strong>o M, Sion C. F<strong>in</strong>ancial consequences of<br />
hospital-acquired bacteraemia <strong>in</strong> three Belgian hospitals <strong>in</strong> 2003 and 2004. J Hosp Infect.<br />
2008;68(1):9-16.<br />
37. Ronveaux O, Mertens R, Dupont Y. Surgical wound <strong>in</strong>fection surveillance: results from the<br />
Belgian hospital network. Acta Chir Belg. 1996;96(1):3-10.<br />
38. Mahieu LM, Buitenweg N, Beutels P, De Dooy JJ. Additional hospital stay and charges due to<br />
hospital-acquired <strong>in</strong>fections <strong>in</strong> a neonatal <strong>in</strong>tensive care unit. J Hosp Infect. 2001;47(3):223-9.<br />
39. Digiov<strong>in</strong>e B, Chenoweth C, Watts C, Higg<strong>in</strong>s M. The attributable mortality and costs of<br />
primary nosocomial bloodstream <strong>in</strong>fections <strong>in</strong> the <strong>in</strong>tensive care unit. Am J Respir Crit Care<br />
Med. 1999;160(3):976-81.<br />
40. Morano Amado LE, Del Campo Perez V, L<strong>op</strong>ez Miragaya I, Mart<strong>in</strong>ez Vazquez MJ, Vazquez<br />
Alvarez O, Pedreira Andrade JD. Nosocomial bacteremia <strong>in</strong> the adult patient. Study of<br />
associated costs. Rev Cl<strong>in</strong> Esp. 2002;202(9):476-84.<br />
41. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream <strong>in</strong>fection <strong>in</strong> critically ill patients.<br />
Excess length of stay, extra costs, and attributable mortality. Jama. 1994;271(20):1598-601.